Cambiar Investors LLC Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Cambiar Investors LLC decreased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 27.6% during the third quarter, according to its most recent filing with the SEC. The firm owned 16,733 shares of the company's stock after selling 6,379 shares during the period. Cambiar Investors LLC owned 0.09% of Addus HomeCare worth $2,226,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. New York State Teachers Retirement System increased its holdings in shares of Addus HomeCare by 1.2% in the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock valued at $1,132,000 after acquiring an additional 100 shares during the period. Integrated Advisors Network LLC bought a new stake in Addus HomeCare during the third quarter valued at about $523,000. Smith Group Asset Management LLC grew its stake in Addus HomeCare by 25.4% in the third quarter. Smith Group Asset Management LLC now owns 4,903 shares of the company's stock valued at $652,000 after purchasing an additional 993 shares during the last quarter. J.W. Cole Advisors Inc. bought a new position in Addus HomeCare in the third quarter worth about $251,000. Finally, State of Alaska Department of Revenue lifted its position in shares of Addus HomeCare by 7.6% during the third quarter. State of Alaska Department of Revenue now owns 10,215 shares of the company's stock valued at $1,358,000 after buying an additional 721 shares during the last quarter. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Trading Up 1.5 %

Shares of ADUS stock traded up $1.85 during mid-day trading on Friday, reaching $126.27. The stock had a trading volume of 146,545 shares, compared to its average volume of 130,769. Addus HomeCare Co. has a 1-year low of $80.68 and a 1-year high of $136.12. The firm has a market cap of $2.29 billion, a price-to-earnings ratio of 29.92, a PEG ratio of 2.28 and a beta of 1.04. The business's fifty day moving average is $130.02 and its 200-day moving average is $120.10.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. Addus HomeCare's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $0.94 EPS. On average, analysts forecast that Addus HomeCare Co. will post 4.57 earnings per share for the current year.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now directly owns 3,366 shares of the company's stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now directly owns 3,366 shares in the company, valued at $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,917 shares of company stock valued at $3,050,082 over the last 90 days. Insiders own 4.60% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ADUS. TD Cowen lifted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research report on Thursday, August 8th. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. Royal Bank of Canada reissued an "outperform" rating and issued a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. KeyCorp started coverage on Addus HomeCare in a research note on Friday, October 11th. They set an "overweight" rating and a $150.00 target price on the stock. Finally, StockNews.com cut Addus HomeCare from a "strong-buy" rating to a "buy" rating in a research note on Sunday, July 7th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Addus HomeCare presently has an average rating of "Moderate Buy" and a consensus target price of $131.38.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.